These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 23485994)
1. The impact of computed tomography on early glottic cancer outcomes. Mourad WF; Hu KS; Shourbaji RA; Ishihara D; Lin W; Kumar M; Blakaj DM; Harrison LB Onkologie; 2013; 36(3):83-6. PubMed ID: 23485994 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up and pattern of failure for T1-T2 glottic cancer after definitive radiation therapy. Mourad WF; Hu KS; Shourbaji RA; Woode R; Harrison LB Am J Clin Oncol; 2013 Dec; 36(6):580-3. PubMed ID: 22868239 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521 [TBL] [Abstract][Full Text] [Related]
4. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension. Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660 [TBL] [Abstract][Full Text] [Related]
5. T1-2 glottic cancer treated with radiotherapy and/or surgery. Shelan M; Anschuetz L; Schubert AD; Bojaxhiu B; Dal Pra A; Behrensmeier F; Aebersold DM; Giger R; Elicin O Strahlenther Onkol; 2017 Dec; 193(12):995-1004. PubMed ID: 28474090 [TBL] [Abstract][Full Text] [Related]
6. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer. Rutkowski T; Wygoda A; Składowski K; Hejduk B; Rutkowski R; Kołosza Z; Maciejewski B Strahlenther Onkol; 2013 Oct; 189(10):861-6. PubMed ID: 23982169 [TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors. Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035 [TBL] [Abstract][Full Text] [Related]
10. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone. Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025 [TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for management of t1-t2 glottic cancer at a private practice. Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812 [TBL] [Abstract][Full Text] [Related]
12. Conventional fractionation should not be the standard of care for T2 glottic cancer. Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654 [TBL] [Abstract][Full Text] [Related]
13. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer. Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system. Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969 [TBL] [Abstract][Full Text] [Related]
15. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy. Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982 [TBL] [Abstract][Full Text] [Related]
16. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Mourad WF; Shasha D; Blakaj DM; Khorsandi AS; Shourbaji RA; Glanzman J; Kabarriti R; Young R; Patel S; Katsoulakis E; Gámez M; Woode R; Lazarus C; Concert C; Hu KS; Harrison LB Anticancer Res; 2013 Oct; 33(10):4483-9. PubMed ID: 24123019 [TBL] [Abstract][Full Text] [Related]
18. Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients. Hansen O; Larsen S; Bastholt L; Godballe C; Jørgensen KE Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):789-94. PubMed ID: 15708258 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267 [TBL] [Abstract][Full Text] [Related]
20. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy. Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]